GET THE APP

Development of Novel Folate Conjugated Nanoparticles Based Skin Lotion for Skin Cancer Treatment: in vitro Characterization and In vivo Study | Abstract
Internal Medicine: Open Access

Internal Medicine: Open Access
Open Access

ISSN: 2165-8048

Abstract

Development of Novel Folate Conjugated Nanoparticles Based Skin Lotion for Skin Cancer Treatment: in vitro Characterization and In vivo Study

Anshita Gupta, Chanchal Deep Kaur, Shailendra Saraf and Saraf Swarnlata*

Quercetin a natural flavanoid has been extensively investigated for its anticancer activity. However, the major disadvantage remained its poor aqueous solubility. In the present research, we investigated the efficacy of folate conjugated quercetin nanoparticles in vitro and further formulated its lotion and studied its skin permeation ability with In vivo activity. The in vitro cellular uptake and antiproliferative potentials of folate conjugated quercetin nanoparticles were evaluated using HaCaT, KB and A431 cell lines. The results showed robust cellular uptake of folate conjugated quercetin nanaoparticles by cell lines. ROS study and Intracellular GSH study revealed that folate conjugated Qu-NPs remarkably reduces the intracellular reactive oxygen species generation and release of GSH. Cells viability studies showed that folate conjugated quercetin nanaoparticless were found to exert profound effect at a concentration of 20 μM on all three cell lines as compared to non-conjugated quercetin nanaoparticles, in a shorter span of time. The skin permeability of the formulation was compared with the marketed drug and was estimated by CLSM study. In vivo studies supported the in vitro activity of folate conjugated quercetin nanoparticles by reducing the epidermal hyperplasia, inflammation and lesion formation.

Published Date: 2022-01-31; Received Date: 2022-01-03